People with asthma are likely to have worse symptoms when they get the flu because they have weaker immune systems, new University of Southampton research has shown. A study led by the university's Dr Ben Nicholas and published in the Journal of Allergy and Clinical Immunology, assessed lung samples from asthmatics and healthy volunteers. The samples were exposed to influenza and their reactions analyzed.
Nicholas, who led the study under the NIHR Southampton Respiratory Biomedical Research Unit, said, “We wanted to look into whether immune system differences explain why asthmatics are more likely to end up in hospital if they get flu than the general population. This is important, as flu can cause a person’s asthma symptoms to get worse. The samples from healthy people showed a strong immune system-triggering reaction to the flu virus. But in lung samples from asthma patients, this reaction was much weaker. We hope these results help researchers better understand why asthmatics are more affected by influenza and help find new treatments for common lung infections, which often make asthma symptoms worse.”
The research method Nicholas used is unlike other techniques, which separate and grow a single layer of cells in a dish. Instead, Nicholas kept the whole sample intact which allowed him to study a pin-head sized piece of lung in the lab, as it would be found in the body.
The study was supported by, and conducted in collaboration with Synairgen, a University of Southampton spin-out company, and formed part of U-BIOPRED, a large-scale European project using information and samples from adults and children to learn more about different types of asthma.
More research is now needed to investigate whether the difference in immune responses is due to the asthma itself, or the daily medications used by participating asthmatics to control their condition.
Source: University of Southampton
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.